Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 14 studies | 23% ± 8% | |
monocyte | 14 studies | 24% ± 8% | |
classical monocyte | 14 studies | 21% ± 7% | |
conventional dendritic cell | 13 studies | 24% ± 9% | |
non-classical monocyte | 12 studies | 29% ± 11% | |
dendritic cell | 11 studies | 27% ± 14% | |
myeloid cell | 5 studies | 24% ± 7% | |
mast cell | 3 studies | 20% ± 2% | |
mononuclear phagocyte | 3 studies | 25% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 0% | |
natural killer cell | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 37% ± 29% | |
GABAergic neuron | 3 studies | 19% ± 2% | |
glutamatergic neuron | 3 studies | 26% ± 4% | |
leukocyte | 3 studies | 23% ± 6% | |
group 3 innate lymphoid cell | 3 studies | 20% ± 2% | |
astrocyte | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 678.92 | 1445 / 1445 | 100% | 28.54 | 183 / 183 |
lung | 100% | 1507.74 | 578 / 578 | 100% | 29.69 | 1154 / 1155 |
breast | 100% | 915.76 | 459 / 459 | 100% | 39.23 | 1116 / 1118 |
prostate | 100% | 876.47 | 245 / 245 | 100% | 36.27 | 501 / 502 |
stomach | 100% | 586.19 | 359 / 359 | 100% | 32.66 | 285 / 286 |
ovary | 100% | 485.38 | 180 / 180 | 100% | 31.26 | 428 / 430 |
bladder | 100% | 734.81 | 21 / 21 | 99% | 35.18 | 501 / 504 |
intestine | 100% | 747.81 | 965 / 966 | 99% | 30.70 | 524 / 527 |
uterus | 100% | 745.99 | 170 / 170 | 99% | 27.49 | 455 / 459 |
skin | 100% | 1329.10 | 1808 / 1809 | 99% | 25.44 | 465 / 472 |
thymus | 100% | 589.20 | 651 / 653 | 96% | 15.72 | 583 / 605 |
kidney | 100% | 560.81 | 89 / 89 | 94% | 18.69 | 850 / 901 |
pancreas | 98% | 522.13 | 322 / 328 | 96% | 28.23 | 171 / 178 |
brain | 91% | 422.13 | 2404 / 2642 | 100% | 28.90 | 702 / 705 |
liver | 95% | 407.27 | 215 / 226 | 84% | 16.63 | 340 / 406 |
adrenal gland | 99% | 401.81 | 256 / 258 | 39% | 3.98 | 90 / 230 |
adipose | 100% | 1035.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.53 | 29 / 29 |
spleen | 100% | 817.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.56 | 1 / 1 |
blood vessel | 100% | 909.79 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1323.40 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 557.92 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 17.10 | 76 / 80 |
muscle | 23% | 47.46 | 182 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007254 | Biological process | JNK cascade |
GO_0051260 | Biological process | protein homooligomerization |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0070427 | Biological process | nucleotide-binding oligomerization domain containing 1 signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_1902523 | Biological process | positive regulation of protein K63-linked ubiquitination |
GO_0035739 | Biological process | CD4-positive, alpha-beta T cell proliferation |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0001961 | Biological process | positive regulation of cytokine-mediated signaling pathway |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0033092 | Biological process | positive regulation of immature T cell proliferation in thymus |
GO_2000563 | Biological process | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0070671 | Biological process | response to interleukin-12 |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0033080 | Biological process | immature T cell proliferation in thymus |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0070673 | Biological process | response to interleukin-18 |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0070431 | Biological process | nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0002827 | Biological process | positive regulation of T-helper 1 type immune response |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0098792 | Biological process | xenophagy |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0007249 | Biological process | canonical NF-kappaB signal transduction |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0071224 | Biological process | cellular response to peptidoglycan |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0034134 | Biological process | toll-like receptor 2 signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0097202 | Biological process | activation of cysteine-type endopeptidase activity |
GO_1904417 | Biological process | positive regulation of xenophagy |
GO_0002250 | Biological process | adaptive immune response |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042742 | Biological process | defense response to bacterium |
GO_0006915 | Biological process | apoptotic process |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0045627 | Biological process | positive regulation of T-helper 1 cell differentiation |
GO_0071225 | Biological process | cellular response to muramyl dipeptide |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031982 | Cellular component | vesicle |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0089720 | Molecular function | caspase binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0030274 | Molecular function | LIM domain binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0004706 | Molecular function | JUN kinase kinase kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0050700 | Molecular function | CARD domain binding |
GO_0042803 | Molecular function | protein homodimerization activity |
Gene name | RIPK2 |
Protein name | Receptor-interacting serine-threonine kinase 2 isoform b Receptor interacting serine/threonine kinase 2 (Receptor-interacting serine-threonine kinase 2 isoform 2) Receptor-interacting serine-threonine kinase 2 isoform 1 Receptor interacting serine/threonine kinase 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) |
Synonyms | UNQ277/PRO314/PRO34092 CARDIAK RICK RIP2 |
Description | FUNCTION: Serine/threonine/tyrosine-protein kinase that plays an essential role in modulation of innate and adaptive immune responses . Acts as a key effector of NOD1 and NOD2 signaling pathways: upon activation by bacterial peptidoglycans, NOD1 and NOD2 oligomerize and recruit RIPK2 via CARD-CARD domains, leading to the formation of RIPK2 filaments . Once recruited, RIPK2 autophosphorylates and undergoes 'Lys-63'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3, as well as 'Met-1'-linked (linear) polyubiquitination by the LUBAC complex, becoming a scaffolding protein for downstream effectors . 'Met-1'-linked polyubiquitin chains attached to RIPK2 recruit IKBKG/NEMO, which undergoes 'Lys-63'-linked polyubiquitination in a RIPK2-dependent process . 'Lys-63'-linked polyubiquitin chains attached to RIPK2 serve as docking sites for TAB2 and TAB3 and mediate the recruitment of MAP3K7/TAK1 to IKBKG/NEMO, inducing subsequent activation of IKBKB/IKKB . In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis . The protein kinase activity is dispensable for the NOD1 and NOD2 signaling pathways . Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappa-B activation by NOD2 . Also involved in adaptive immunity: plays a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation . Plays a role in the inactivation of RHOA in response to NGFR signaling . . |
Accessions | A0A0S2Z4Z8 O43353 Q6Q322 ENST00000517696.1 E5RGK6 ENST00000522965.1 E7ERW9 ENST00000220751.5 [O43353-1] |